Annals of the New York Academy of Sciences

Cover image for Vol. 1222 Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010

March 2011

Volume 1222 Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010

Pages vii–vii, 1–99

  1. Foreword

    1. Top of page
    2. Foreword
    3. Introduction
    4. Original Articles
    1. Foreword by Ban Ki-moon (page vii)

      Ban Ki-moon

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05995.x

  2. Introduction

    1. Top of page
    2. Foreword
    3. Introduction
    4. Original Articles
  3. Original Articles

    1. Top of page
    2. Foreword
    3. Introduction
    4. Original Articles
    1. Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel (pages 6–13)

      Nancy Krunic, Frank Merante, Sevana Yaghoubian, David Himsworth and Richard Janeczko

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05964.x

    2. Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine (pages 14–18)

      Michelle G. Goveia, Max Ciarlet, Katey E. Owen and Colette S. Ranucci

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05970.x

    3. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives (pages 30–39)

      Newman Yeilding, Philippe Szapary, Carrie Brodmerkel, Jacqueline Benson, Michael Plotnick, Honghui Zhou, Kavitha Goyal, Brad Schenkel, Jill Giles-Komar, Mary Ann Mascelli and Cynthia Guzzo

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05963.x

    4. Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting (pages 40–48)

      Richard Hargreaves, Juan Camilo Arjona Ferreira, David Hughes, Jos Brands, Jeff Hale, Britta Mattson and Sandy Mills

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05961.x

    5. Linezolid, the first oxazolidinone antibacterial agent (pages 49–54)

      Karen L. Leach, Steven J. Brickner, Mark C. Noe and Paul F. Miller

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05962.x

    6. The discovery and development of rivaroxaban (pages 64–75)

      Frank Misselwitz, Scott D. Berkowitz and Elisabeth Perzborn

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05971.x

    7. A review of the history, properties, and use of the immunomodulatory compound lenalidomide (pages 76–82)

      Jerome B. Zeldis, Robert Knight, Mohamad Hussein, Rajesh Chopra and George Muller

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05974.x

    8. Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium (pages 83–89)

      Bach-Yen T. Nguyen, Robin D. Isaacs, Hedy Teppler, Randi Y. Leavitt, Peter Sklar, Marian Iwamoto, Larissa A. Wenning, Michael D. Miller, Joshua Chen, Ramon Kemp, Wei Xu, Robert A. Fromtling, Joseph P. Vacca, Steven D. Young, Michael Rowley, Michael W. Lower, Keith M. Gottesdiener and Daria J. Hazuda

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1749-6632.2011.05972.x

SEARCH

SEARCH BY CITATION